US2009197317A1PendingUtilityA1
TSG-Like Gene
Assignee: CHUGAI PHARMACEUTICAL CO LTDPriority: Sep 6, 1999Filed: Nov 15, 2007Published: Aug 6, 2009
Est. expirySep 6, 2019(expired)· nominal 20-yr term from priority
C07K 14/475A61K 38/00
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A gene encoding a novel protein that is homologous to Drosophila TSG was isolated from a cDNA library derived from the AGM region of mouse embryos by using an originally developed cloning method specific to a gene encoding a membrane secretory protein. This gene is useful in developing drugs that regulate hematopoietic stem cell generation, immune and hematopoietic functions, etc.
Claims
exact text as granted — not AI-modified1 . A substantially purified polypeptide comprising residues 25-222 of SEQ ID NO:2.
2 . The polypeptide of claim 1 , wherein the polypeptide further comprises an initiator methionine or a signal peptide.
3 . The polypeptide of claim 1 , wherein the polypeptide consists of residues 25-222 of SEQ ID NO:2 plus an initiator methionine or a signal peptide.
4 . The polypeptide of claim 1 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO:2.
5 . The polypeptide of claim 1 , wherein the polypeptide consists of the amino acid sequence of SEQ ID NO:2.
6 . The polypeptide of claim 1 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO:2 fused to a second amino acid sequence.
7 . The polypeptide of claim 1 , wherein the polypeptide comprises the amino acid sequence of residues 25-222 of SEQ ID NO:2 fused to a second amino acid sequence.
8 . The polypeptide of claim 7 , wherein the second amino acid sequence is a peptide selected from the group consisting of glutathione S-transferase, FLAG, six histidine residues, influenza agglutinin (HA), human c-myc fragment, VSV-GP fragment, p18HIV fragment, T7-tag, HSV-tag, E-tag, SV40T antigen fragment, lck tag, α-tubulin fragment, B-tag, Protein C fragment, immunoglobulin constant region, β-galactosidase, Green Fluorescent Protein (GFP), and maltose binding protein.
9 . The polypeptide of claim 7 , wherein the polypeptide comprises an initiator methionine.
10 . The polypeptide of claim 7 , wherein the polypeptide further comprises residues 1-24 of SEQ ID NO:2.
11 . The polypeptide of claim 7 , wherein the polypeptide comprises a signal sequence.
12 . A substantially purified polypeptide that (a) has at least 95% identity to the amino acid sequence of SEQ ID NO:2, and (b) binds to BMP2/4.
13 . The polypeptide of claim 12 , wherein the polypeptide has at least 98% identity to the amino acid sequence of SEQ ID NO:2.
14 . The polypeptide of claim 12 , wherein the polypeptide has at least 99% identity to the amino acid sequence of SEQ ID NO:2.
15 . A substantially purified polypeptide comprising the amino acid sequence of SEQ ID NO:2 or a fragment thereof, wherein the fragment is at least 40% of the length of the sequence shown as SEQ ID NO:2, and the fragment binds to BMP2/4.
16 . A substantially purified polypeptide comprising the amino acid sequence of SEQ ID NO:2 in which 5 or fewer amino acids are substituted, deleted, and/or inserted, and the polypeptide binds to BMP2/4.Join the waitlist — get patent alerts
Track US2009197317A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.